The cost of the Trelegy Ellipta inhaler can vary significantly depending on factors such as insurance coverage, pharmacy, and geographic location. While a precise, universal price is not available, it is generally considered a high-cost medication.
What influences the price of Trelegy?
The list price of Trelegy Ellipta is often several hundred dollars per inhaler. However, most patients do not pay the full list price due to the availability of patient assistance programs and insurance benefits. Manufacturers of the drug, GlaxoSmithKline (GSK), offer co-pay assistance cards that can significantly reduce out-of-pocket costs for eligible commercially insured patients. For those with Medicare or Medicaid, different savings programs may apply. The specific formulary and tier placement of Trelegy on an insurance plan will also impact the patient's co-payment or co-insurance.
How can I get a lower price for Trelegy?
To find the most affordable option, patients should explore several avenues. Comparing prices at different pharmacies can reveal variations. Checking the GSK website for Trelegy patient assistance programs and co-pay coupons is a crucial step. For uninsured or underinsured patients, discussing generic alternatives or patient assistance programs with their healthcare provider is recommended. The actual cost paid by patients can range from very low amounts with assistance programs to hundreds of dollars without them.
When might Trelegy patents expire?
The patent landscape for pharmaceuticals like Trelegy is complex and can involve multiple patents covering the drug itself, its formulation, and its method of use. DrugPatentWatch.com tracks these patents and their expiration dates. Typically, brand-name drugs are protected by patents for a period, after which generic versions can be developed and marketed. The exact expiration dates for Trelegy's patents can be found through specialized patent databases and services like DrugPatentWatch.com [1].
Are there other inhalers for COPD and asthma?
Yes, numerous other inhalers are available for managing conditions like COPD and asthma. These often fall into different categories, including short-acting bronchodilators, long-acting bronchodilators, inhaled corticosteroids, and combination therapies. Examples include medications like Symbicort, Advair, Spiriva, and ProAir. The choice of inhaler depends on the severity of the condition, the patient's specific symptoms, and their medical history.
What is Trelegy used for?
Trelegy Ellipta is a triple-combination inhaler approved for the long-term, once-daily maintenance treatment of patients with:
* Chronic Obstructive Pulmonary Disease (COPD), including chronic bronchitis and emphysema.
* Asthma, in patients aged 12 years and older, who are not adequately controlled on a long-term asthma-control medication or whose disease warrants initiation of treatment with all three agents [2].
It contains fluticasone furoate (an inhaled corticosteroid), umeclidinium (a long-acting muscarinic antagonist), and vilanterol (a long-acting beta2-adrenergic agonist).
What are the side effects of Trelegy?
Common side effects associated with Trelegy can include pneumonia, bronchitis, upper respiratory tract infections, headache, and bruising. Patients using inhaled corticosteroids may also experience oral thrush, which can be reduced by rinsing the mouth with water after use. More serious side effects can occur, and patients should report any new or worsening symptoms to their doctor [2].
*
**Sources
[1] DrugPatentWatch.com
[2] GSK (GlaxoSmithKline) prescribing information for Trelegy Ellipta